Wednesday, August 09, 2017 2:37:33 PM
But part of the thesis of cannabinoid drug development is that A. you already know the compounds are efficacious & B. there is already an established safety profile.
I found out that in the ZYN002 trials for PTSD, that patients were not wash the application site of the cream for 12 Hours.
http://zynerba.com/wp-content/uploads/2016/10/ZYN-002-MHSRS-poster-8-9-16v5-1-1.pdf
Someone on Twitter wondered that maybe in the latest trials Zynerba weren't as stringent about the application site post-admin, or weren't allowed to be, compared to their pre-clinical research.
Anyways, congrats to anyone Who caught the ZYNE knife and is riding the wave!
FEATURED Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • Apr 22, 2024 8:49 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM